Skip to main content
Premium Trial:

Request an Annual Quote

Too Much


The US Preventive Services Task Force doesn't recommend routine ovarian cancer screening for women with no symptoms, but a new study shows that doctors may not be following this guideline, reports Katherine Hobson at the Wall Street Journal Health Blog. The study, published in the Annals of Internal Medicine, found that 28.5 percent of the 1,088 primary care doctors surveyed "sometimes" or "almost always" offer or order ovarian cancer screening tests like trans-vaginal ultrasound or CA-125 antigen screening for women at low risk of ovarian cancer. For women at medium risk of cancer, that number went up to 65.4 percent, Hobson says, even though there is no evidence that the benefits of these tests outweigh the risks. "About a third of physicians reported believing that ultrasound or CA-125 blood testing is an effective screening test for ovarian cancer," she adds. "It's unclear why that is." Some physicians also said they'd order tests if requested by the patient, even if they, themselves, didn't believe in the efficacy of the tests.

The study's authors tell Hobson that there may be a need for clinical tools to help doctors and patients understand the level of risk for ovarian cancer compared with the benefits and harms of a particular test.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.